Emerald Cloud Lab: Difference between revisions
m pipe |
→History: sections |
||
| Line 24: | Line 24: | ||
==History== |
==History== |
||
===Founding=== |
|||
D.J. Kleinbaum and Brian Frezza grew up together on Emerald Drive, in the Philadelphia suburbs, and they long wanted to build a biotechnology business together. In 2010, after completing their PhDs, they came together to found Emerald Therapeutics in an effort to develop "antiviral therapy for diseases such as hepatitis and HIV". During this time, they experienced problems with laboratory hardware and software. Hardware often comes from disparate manufacturers, software is often rudimentary, and output can vary in formatting. To simplify laboratory testing, the group wrote centralized management software for the different machines and a database to store all metadata and results.<ref name=Bloomberg2014>{{cite web |last1=Vance |first1=Ashlee |title=Emerald Therapeutics: Biotech Lab for Hire |url=https://www.bloomberg.com/news/articles/2014-07-03/emerald-therapeutics-biotech-lab-for-hire |website=Bloomberg |accessdate=30 October 2019 |archiveurl=https://web.archive.org/web/20170705210722/https://www.bloomberg.com/news/articles/2014-07-03/emerald-therapeutics-biotech-lab-for-hire |archivedate=5 July 2017 |date=3 July 2014 |url-status=live}}</ref> This "laboratory operating system" became Emerald Therapeutic's first product, launched in 2014 under the name Emerald Cloud Lab.{{citation needed|reason=Is this actually the first product? Is this the right year?|date=November 2019}} |
D.J. Kleinbaum and Brian Frezza grew up together on Emerald Drive, in the Philadelphia suburbs, and they long wanted to build a biotechnology business together. In 2010, after completing their PhDs, they came together to found Emerald Therapeutics in an effort to develop "antiviral therapy for diseases such as hepatitis and HIV". During this time, they experienced problems with laboratory hardware and software. Hardware often comes from disparate manufacturers, software is often rudimentary, and output can vary in formatting. To simplify laboratory testing, the group wrote centralized management software for the different machines and a database to store all metadata and results.<ref name=Bloomberg2014>{{cite web |last1=Vance |first1=Ashlee |title=Emerald Therapeutics: Biotech Lab for Hire |url=https://www.bloomberg.com/news/articles/2014-07-03/emerald-therapeutics-biotech-lab-for-hire |website=Bloomberg |accessdate=30 October 2019 |archiveurl=https://web.archive.org/web/20170705210722/https://www.bloomberg.com/news/articles/2014-07-03/emerald-therapeutics-biotech-lab-for-hire |archivedate=5 July 2017 |date=3 July 2014 |url-status=live}}</ref> This "laboratory operating system" became Emerald Therapeutic's first product, launched in 2014 under the name Emerald Cloud Lab.{{citation needed|reason=Is this actually the first product? Is this the right year?|date=November 2019}} |
||
===Business development=== |
|||
| ⚫ | The business got its second round of funding by 2014 from the [[Founders Fund]], a venture capital firm founded by [[Peter Thiel]]. This funding round provided $13.5 million |
||
As of 2014, Emerald Cloud Lab offered 40 types of laboratory tests, with intent to expand to over a hundred by the next year.<ref name=Bloomberg2014/> |
|||
Researchers and pharmaceutical groups have long been concerned about the lack of [[reproducibility crisis|reproducibility of laboratory testing]] in the biomedical field. A 2017 paper used Emerald Cloud Lab and a similar company, [[Transcriptic]], to explore how robotic lab automation could ameliorate this problem. The paper concludes that, "we believe that robotic labs can provide the basis for performing a large percentage of basic biomedical research in a reproducible and transparent fashion".<ref>{{cite journal |pmid=29134146|pmc=5681851|year=2017|last1=Groth|first1=P.|title=Indicators for the use of robotic labs in basic biomedical research: A literature analysis|journal=PeerJ|volume=5|pages=e3997|last2=Cox|first2=J.|doi=10.7717/peerj.3997}}</ref> Frezza has described this laboratory inconsistency as one specific reason for the development of Emerald Cloud Lab and the use of automation.<ref name="BeerCloud2015" /> |
Researchers and pharmaceutical groups have long been concerned about the lack of [[reproducibility crisis|reproducibility of laboratory testing]] in the biomedical field. A 2017 paper used Emerald Cloud Lab and a similar company, [[Transcriptic]], to explore how robotic lab automation could ameliorate this problem. The paper concludes that, "we believe that robotic labs can provide the basis for performing a large percentage of basic biomedical research in a reproducible and transparent fashion".<ref>{{cite journal |pmid=29134146|pmc=5681851|year=2017|last1=Groth|first1=P.|title=Indicators for the use of robotic labs in basic biomedical research: A literature analysis|journal=PeerJ|volume=5|pages=e3997|last2=Cox|first2=J.|doi=10.7717/peerj.3997}}</ref> Frezza has described this laboratory inconsistency as one specific reason for the development of Emerald Cloud Lab and the use of automation.<ref name="BeerCloud2015" /> |
||
==Financing== |
|||
| ⚫ | |||
==References== |
==References== |
||
Revision as of 22:14, 30 March 2020
 | |
| Company type | Private |
|---|---|
| Predecessor | Emerald Therapeutics |
| Founded | 2010 |
| Founder |
|
| Headquarters | , United States |
| Website | emeraldcloudlab |
Emerald Cloud Lab is a privately-owned biotech startup. The company is among the first to offer laboratory automation through the software as a service model. D.J. Kleinbaum and Brian Frezza founded Emerald Cloud Lab in 2010.[1]
History
Founding
D.J. Kleinbaum and Brian Frezza grew up together on Emerald Drive, in the Philadelphia suburbs, and they long wanted to build a biotechnology business together. In 2010, after completing their PhDs, they came together to found Emerald Therapeutics in an effort to develop "antiviral therapy for diseases such as hepatitis and HIV". During this time, they experienced problems with laboratory hardware and software. Hardware often comes from disparate manufacturers, software is often rudimentary, and output can vary in formatting. To simplify laboratory testing, the group wrote centralized management software for the different machines and a database to store all metadata and results.[2] This "laboratory operating system" became Emerald Therapeutic's first product, launched in 2014 under the name Emerald Cloud Lab.[citation needed]
Business development
As of 2014, Emerald Cloud Lab offered 40 types of laboratory tests, with intent to expand to over a hundred by the next year.[2]
Researchers and pharmaceutical groups have long been concerned about the lack of reproducibility of laboratory testing in the biomedical field. A 2017 paper used Emerald Cloud Lab and a similar company, Transcriptic, to explore how robotic lab automation could ameliorate this problem. The paper concludes that, "we believe that robotic labs can provide the basis for performing a large percentage of basic biomedical research in a reproducible and transparent fashion".[3] Frezza has described this laboratory inconsistency as one specific reason for the development of Emerald Cloud Lab and the use of automation.[1]
Financing
The business got its second round of funding by 2014 from the Founders Fund, a venture capital firm founded by Peter Thiel. This funding round provided $13.5 million.[2]
References
- ^ a b Garner, Rochelle. "Science labs in the cloud: Champagne discoveries, beer budget". Cnet. Archived from the original on 28 October 2015. Retrieved 29 October 2019.
- ^ a b c Vance, Ashlee (3 July 2014). "Emerald Therapeutics: Biotech Lab for Hire". Bloomberg. Archived from the original on 5 July 2017. Retrieved 30 October 2019.
- ^ Groth, P.; Cox, J. (2017). "Indicators for the use of robotic labs in basic biomedical research: A literature analysis". PeerJ. 5: e3997. doi:10.7717/peerj.3997. PMC 5681851. PMID 29134146.
{{cite journal}}: CS1 maint: unflagged free DOI (link)